A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced SarcomaCiara M. Kelly, Sandra P. D’Angelo, Li‐Xuan Qin et al.|Clinical Cancer Research|2023Cited by 71
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcomaSandra P. D’Angelo, William D. Tap, Joseph P. Erinjeri et al.|Nature Communications|2022Cited by 61
A phase I/II trial of the PD-1 inhibitor retifanlimab (R) in combination with gemcitabine and docetaxel (GD) as first-line therapy in patients (Pts) with advanced soft-tissue sarcoma (STS).Evan Rosenbaum, Sandra P. D’Angelo, Li‐Xuan Qin et al.|Journal of Clinical Oncology|2022Cited by 6
Presence of immune infiltrates, increased expression of transposable elements, and viral response pathways in sarcoma associate with response to checkpoint inhibition.Benjamin A. Nacev, Sandra P. D’Angelo, Martina Bradić et al.|Journal of Clinical Oncology|2022Cited by 1
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapyBenjamin A. Nacev, Sandra P. D’Angelo, Martina Bradić et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 1